These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35408669)
21. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs. Moreno P; Ginel PJ Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508 [TBL] [Abstract][Full Text] [Related]
22. Revisiting the effects of spectral interfering substances in optical end-point coagulation assays. Seheult JN; Dalenberg D; Sridharan MR; Stuart M; Moericke K; Cardel L; Heikal N; Chen D; Pruthi RK Int J Lab Hematol; 2021 Oct; 43(5):1181-1190. PubMed ID: 33455065 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of Novel Tranexamic Acid/Montmorillonite Intercalation Composite, as a New Type of Hemostatic Material. Ma F; Sui S; Yang Z; Ye T; Yang L; Han P; Gan H; Wu Z; Gu R; Zhu X; Li F; Meng Z; Jiang Z; Dou G Biomed Res Int; 2022; 2022():3963681. PubMed ID: 35265711 [TBL] [Abstract][Full Text] [Related]
24. Methodical aspects of blood coagulation measurements in birds applying commercial reagents--a pilot study. Guddorf V; Kummerfeld N; Mischke R Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):322-7. PubMed ID: 25080826 [TBL] [Abstract][Full Text] [Related]
25. In vitro studies on a novel micelle-forming peptide with anticoagulant activity. Ramesh CV; Jayakumar R; Puvanakrishnan R Int J Pept Protein Res; 1995 Apr; 45(4):386-90. PubMed ID: 7601613 [TBL] [Abstract][Full Text] [Related]
26. Ovariectomy differential influence on some hemostatic markers of mice and rats. Lemini C; Jaimez R; Figueroa A; Martinez-Mota L; Avila ME; Medina M Exp Anim; 2015; 64(1):81-9. PubMed ID: 25312504 [TBL] [Abstract][Full Text] [Related]
27. Dynamic change of coagulation and anticoagulation markers of patients with acute cerebral infarction during intravenous urokinase thrombolysis. Ji X; Meng R; Zhou J; Ling F; Jia J Neurol Res; 2006 Jan; 28(1):46-9. PubMed ID: 16464362 [TBL] [Abstract][Full Text] [Related]
28. Influence of sex on activated partial thromboplastin time (aPTT) and prothrombin time (PT) in sheep. Leite Carlos MM; Melo MM; Soto-Blanco B Vet Ital; 2017 Sep; 53(3):255-258. PubMed ID: 29152708 [TBL] [Abstract][Full Text] [Related]
29. Coagulation in Liver Disease. Hoffman M Semin Thromb Hemost; 2015 Jul; 41(5):447-54. PubMed ID: 26049068 [TBL] [Abstract][Full Text] [Related]
30. Chemical constituents from Sedum aizoon and their hemostatic activity. Lin Z; Fang Y; Huang A; Chen L; Guo S; Chen J Pharm Biol; 2014 Nov; 52(11):1429-34. PubMed ID: 25026341 [TBL] [Abstract][Full Text] [Related]
31. The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method. Hernaningsih Y; Akualing JS Medicine (Baltimore); 2017 Sep; 96(38):e7976. PubMed ID: 28930835 [TBL] [Abstract][Full Text] [Related]
32. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels. Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317 [TBL] [Abstract][Full Text] [Related]
33. [Interpretation of hemostatic and fibrinolytic markers]. Asakura H Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880 [TBL] [Abstract][Full Text] [Related]
34. Biocompatible sulfenamide and sulfonamide derivatives of metformin can exert beneficial effects on plasma haemostasis. Markowicz-Piasecka M; Huttunen KM; Mikiciuk-Olasik E; Sikora J Chem Biol Interact; 2018 Jan; 280():15-27. PubMed ID: 29217384 [TBL] [Abstract][Full Text] [Related]
36. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Welsch DJ; Novotny WF; Wun TC Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340 [TBL] [Abstract][Full Text] [Related]
37. Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis. Verhoef D; Tjalma AVR; Cheung KL; Reitsma PH; Bos MHA Thromb Res; 2021 Feb; 198():154-162. PubMed ID: 33348189 [TBL] [Abstract][Full Text] [Related]
38. Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery. Choi TS; Greilich PE; Shi C; Wilson JS; Keller A; Kroll MH Am J Clin Pathol; 2002 Jan; 117(1):74-8. PubMed ID: 11789734 [TBL] [Abstract][Full Text] [Related]
39. Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages. Wiesel ML; Faradji A; Grunebaum L; Bohbot A; Schmitt-Goguel M; Bergerat JP; Cazenave JP; Oberling F Ann Hematol; 1992 Aug; 65(2):75-8. PubMed ID: 1324742 [TBL] [Abstract][Full Text] [Related]
40. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect. Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]